Overview
GenMed Innovations specializes in advanced biotechnology solutions aimed at accelerating the drug discovery process. Our proprietary platform leverages extensive data analytics and predictive modeling, significantly reducing the time and cost associated with bringing new drugs to market. As we transition from the development phase to commercial readiness, we have achieved promising preliminary results in initial trials, attracting interest from several pharmaceutical companies looking for partnerships. We are actively seeking an investor who shares our vision and can help us realize the full potential of our platform. Currently, we have successfully completed the alpha testing phase of our platform, demonstrating accurate predictions in several drug candidate screenings. Our early traction includes collaborations with two mid-sized pharmaceutical companies, which have provided us valuable feedback and validation of our technology. However, to fully capitalize on this momentum, we require additional funding to enhance our technological capabilities, expand our team, and upscale our marketing efforts to reach a broader audience. Our team consists of experienced professionals with bac…
Use of funds
The $1,500,000 investment will be allocated primarily as follows:
- Product Development (50%): Enhancing our software capabilities and refining algorithms to improve predictive accuracy.
- Marketing (25%): Building a targeted marketing campaign to increase brand awareness and attract new partnerships.
- Team Expansion (15%): Hiring additional data scientists and biotechnologists to support product development.
- Operational Costs (10%): Covering administrative expenses and necessary infrastructure enhancements.
Open case
Open this case to get the detailed business plan and direct contact with the founder or seeker.